123 related articles for article (PubMed ID: 22579302)
1. Enhancing prolonged exposure therapy for posttraumatic stress disorder with D-cycloserine: further support for treatments that promote experience-dependent neuroplasticity.
Krystal JH
Biol Psychiatry; 2012 Jun; 71(11):932-4. PubMed ID: 22579302
[No Abstract] [Full Text] [Related]
2. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
[TBL] [Abstract][Full Text] [Related]
3. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder.
de Kleine RA; Hendriks GJ; Smits JA; Broekman TG; van Minnen A
J Psychiatr Res; 2014 Jan; 48(1):40-6. PubMed ID: 24183818
[TBL] [Abstract][Full Text] [Related]
4. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
[TBL] [Abstract][Full Text] [Related]
5. Lessons learned from D-cycloserine: the promise and limits of drug facilitation of exposure therapy.
Rodebaugh TL; Lenze EJ
J Clin Psychiatry; 2013 Apr; 74(4):415-6. PubMed ID: 23656850
[No Abstract] [Full Text] [Related]
6. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.
Choi DC; Rothbaum BO; Gerardi M; Ressler KJ
Curr Top Behav Neurosci; 2010; 2():279-99. PubMed ID: 21309114
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
9. Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder.
Rothbaum BO
Am J Psychiatry; 2008 Mar; 165(3):293-6. PubMed ID: 18316423
[No Abstract] [Full Text] [Related]
10. Neurocognitive processes in d-cycloserine augmented single-session exposure therapy for anxiety: A randomized placebo-controlled trial.
Reinecke A; Nickless A; Browning M; Harmer CJ
Behav Res Ther; 2020 Jun; 129():103607. PubMed ID: 32229324
[TBL] [Abstract][Full Text] [Related]
11. Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial.
Smits JA; Kauffman BY; Lee-Furman E; Zvolensky MJ; Otto MW; Piper ME; Powers MB; Rosenfield D
Contemp Clin Trials; 2016 May; 48():46-51. PubMed ID: 27015966
[TBL] [Abstract][Full Text] [Related]
12. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder.
Litz BT; Salters-Pedneault K; Steenkamp MM; Hermos JA; Bryant RA; Otto MW; Hofmann SG
J Psychiatr Res; 2012 Sep; 46(9):1184-90. PubMed ID: 22694905
[TBL] [Abstract][Full Text] [Related]
13. Emerging treatments for PTSD.
Cukor J; Spitalnick J; Difede J; Rizzo A; Rothbaum BO
Clin Psychol Rev; 2009 Dec; 29(8):715-26. PubMed ID: 19800725
[TBL] [Abstract][Full Text] [Related]
14. Augmenting transcranial direct current stimulation with (D)-cycloserine for depression: a pilot study.
Chan HN; Alonzo A; Martin DM; Mitchell PB; Sachdev P; Loo CK
J ECT; 2013 Sep; 29(3):196-200. PubMed ID: 23792778
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
[TBL] [Abstract][Full Text] [Related]
16. A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission.
McGuire JF; Wu MS; Piacentini J; McCracken JT; Storch EA
J Clin Psychiatry; 2017 Feb; 78(2):196-206. PubMed ID: 27314661
[TBL] [Abstract][Full Text] [Related]
17. D-cycloserine nasal formulation development for anxiety disorders by using polymeric gels.
Shin Y; Kokate R; Desai V; Bhushan A; Kaushal G
Drug Discov Ther; 2018; 12(3):142-153. PubMed ID: 29998995
[TBL] [Abstract][Full Text] [Related]
18. Pilot Study of a Telehealth-Delivered Medication-Augmented Exposure Therapy Protocol for PTSD.
Olden M; Wyka K; Cukor J; Peskin M; Altemus M; Lee FS; Finkelstein-Fox L; Rabinowitz T; Difede J
J Nerv Ment Dis; 2017 Feb; 205(2):154-160. PubMed ID: 27441461
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
Norberg MM; Krystal JH; Tolin DF
Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of exposure therapy with post-session administration of D-cycloserine.
Tart CD; Handelsman PR; Deboer LB; Rosenfield D; Pollack MH; Hofmann SG; Powers MB; Otto MW; Smits JA
J Psychiatr Res; 2013 Feb; 47(2):168-74. PubMed ID: 23098672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
